• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Infect Dis (Lond) . Does the initial chest radiograph severity in COVID-19 impact the short- and long-term outcome? - a perspective from India

tetano

Editor, Senior Moderator
Infect Dis (Lond)


. 2021 Dec 27;1-10.
doi: 10.1080/23744235.2021.2018135. Online ahead of print.
Does the initial chest radiograph severity in COVID-19 impact the short- and long-term outcome? - a perspective from India


Maria M D'souza[SUP] 1 [/SUP], Aruna Kaushik[SUP] 1 [/SUP], Jeanne Maria Dsouza[SUP] 2 [/SUP], Ratnesh Kanwar[SUP] 1 [/SUP], Vivek Lodhi[SUP] 1 [/SUP], Rajnish Sharma[SUP] 1 [/SUP], Anil Kumar Mishra[SUP] 1 [/SUP]



Affiliations

Abstract

Purpose: The chest radiograph (CXR) is among the most widely used investigations in coronavirus disease 2019 (COVID-19) patients. Little is known about its predictive role on the long-term outcome. The purpose of this study was to explore its association with the short and long-term outcome in COVID-19 patients.
Methods: A total of 1530 patients were assessed for the presence, radiographic pattern and distribution of lung lesions observed on baseline chest radiographs obtained at admission. The Brixia scoring system was applied for semiquantitative assessment of lesion severity. Short-term outcome was determined by clinical severity, duration of hospitalization and mortality. The 1415 survivors in this group were assessed after 5-6 months for the presence of residual symptoms.
Results: About 67% patients had an abnormal baseline CXR. Bilateral involvement with a basal preponderance was observed and ground-glass opacification was the most frequent finding. The Brixia score ranged from 0 to 16, median 2, interquartile range (IQR) [0-6]. About 36% patients were symptomatic on 5-6-month follow-up, with fatigability being the commonest symptom. A good correlation was observed between the CXR score and disease severity as well as duration of hospitalization. On multivariate analysis, the CXR score was found to be a significant independent predictor of in-patient mortality as well as presence of long-term residual symptoms in survivors.
Conclusions: Disease severity as seen on the chest radiograph appears to play an important role in driving the short and long-term consequences of COVID-19 and could serve as a prognostic indicator, which influences short-term management and long-term follow-up.

Keywords: COVID-19; chest radiograph; long-term outcome; short-term outcome.
 
Back
Top Bottom